Clinical Evaluation of the PowerGlide™ Pro Midline Catheter

University Hospital Augsburg50 enrolled

Overview

Clinical evaluation of the PowerGlide™ Pro Midline Catheter in patients with vascular diseases

Clinical evaluation of the PowerGlide™ Pro Midline Catheter in patients with vascular diseases. The selected patients are in need of a long-term i.v. therapy for reasons as antibiotic therapy or alprostadil therapy. The Midline catheter is a device, which is placed via Seldinger's technique to a vein usual on the upper extremity under ultrasound-control.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Pain Catheter Infection

Interventions

PowerGlide™ Pro Midline CatheterDEVICE

Clinical evaluation of the PowerGlide™ Pro Midline Catheter in patients with vascular disease

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * need for i.v. therapy longer than 7 days * poor peripheral vein status * Administration of alprostadil Exclusion Criteria: * pending dialysis * allergy to catheter material * minor age * life threatening conditions * requirement for central venous catheter

Locations (1)

University Hospital Augsburg

Augsburg, Germany

Outcomes

Primary Outcomes

Dwelling Time

Length of catheter in situ time

Time frame: 0-29 days

Secondary Outcomes

Administration of Alprostadil

Feasibility for the usage of Alprostadil measured by patients with development of thrombophlebitis or occlusion

Time frame: 0-29 days

Catheter Complications

Site complications as thrombophlebitis and occlusion

Time frame: 0-29 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.